LFGSX
Price
$37.07
Change
+$0.65 (+1.78%)
Updated
Dec 20 closing price
VIGIX
Price
$214.82
Change
+$2.24 (+1.05%)
Updated
Dec 20 closing price
Ad is loading...

LFGSX vs VIGIX

Header iconLFGSX vs VIGIX Comparison
Open Charts LFGSX vs VIGIXBanner chart's image
Lord Abbett Focused Growth R4
Price$37.07
Change+$0.65 (+1.78%)
VolumeN/A
CapitalizationN/A
Vanguard Growth Index Institutional
Price$214.82
Change+$2.24 (+1.05%)
VolumeN/A
CapitalizationN/A
LFGSX vs VIGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LFGSX vs. VIGIX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFGSX is a Buy and VIGIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 282B vs. LFGSX (82.4M). VIGIX pays higher dividends than LFGSX: VIGIX (0.53) vs LFGSX (0.00). LFGSX was incepted earlier than VIGIX: LFGSX (6 years) vs VIGIX (27 years). LFGSX is a more actively managed with annual turnover of: 169.00 vs. VIGIX (5.00). LFGSX has a lower initial minimum investment than VIGIX: LFGSX (0) vs VIGIX (5000000). LFGSX annual gain was more profitable for investors over the last year : 53.95 vs. VIGIX (34.37). VIGIX return over 5 years is better than : 129.76 vs. LFGSX (114.53).
LFGSXVIGIXLFGSX / VIGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years27 years-
Gain YTD53.69034.272157%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets82.4M282B0%
Annual Yield % from dividends0.000.53-
Returns for 1 year53.9534.37157%
Returns for 3 years27.1332.7783%
Returns for 5 years114.53129.7688%
Returns for 10 yearsN/A298.58-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCL238.437.67
+3.32%
Royal Caribbean Group
ATUS2.640.08
+3.13%
Altice USA
CCCC3.950.11
+2.73%
C4 Therapeutics
PFSI101.661.56
+1.56%
PennyMac Financial Services
ELEV0.58-0.05
-7.30%
Elevation Oncology